Table 1 Classification of outcomes of SmartEye compared with clinicians
Clinicians diagnosis | SmartEye diagnosis | |||||||
|---|---|---|---|---|---|---|---|---|
DR0 | DR1 | DR2 | DR3 | PRP | Other diseases | Disqualification | Total | |
| Â | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) |
No DR | 5377 (58.0%) | 290 (3.1%) | 782 (8.4%) | 223 (2.4%) | 23 (0.2%) | 74 (0.8%) | 2497 (26.9%) | 9266 (100.0%) |
Mild NPDR | 213 (34.5%) | 152 (24.6%) | 88 (14.2%) | 5 (0.8%) | 1 (0.2%) | 7 (1.1%) | 152 (24.6%) | 618 (100.0%) |
Moderate NPDR | 176 (14.8%) | 111 (9.3%) | 583 (49.0%) | 129 (10.8%) | 3 (0.3%) | 4 (0.3%) | 184 (15.5%) | 1190 (100.0%) |
Severe NPDR | 0 (0.0%) | 0 (0.0%) | 6 (8.3%) | 65 (90.3%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) | 72 (100.0%) |
PDR | 0 (0.0%) | 0 (0.0%) | 1 (8.3%) | 8 (66.7%) | 0 (0.0%) | 0 (0.0%) | 3 (25.0%) | 12 (100.0%) |
PRP | 5 (4.9%) | 5 (4.9%) | 28 (27.5%) | 20 (19.6%) | 28 (27.5%) | 0 (0.0%) | 16 (15.7%) | 102 (100.0%) |
Other diseases | 39 (14.2%) | 10 (3.6%) | 71 (25.8%) | 86 (31.3%) | 17 (6.2%) | 1 (0.4%) | 51 (18.5%) | 275 (100.0%) |
Disqualification | 203 (2.4%) | 50 (0.6%) | 595 (7.1%) | 391 (4.7%) | 30 (0.4%) | 3 (0.0%) | 7097 (84.8%) | 8369 (100.0%) |
Total | 6013 (30.2%) | 618 (3.1%) | 2154 (10.8%) | 927 (4.7%) | 102 (0.5%) | 10,001 (50.2%) | 89 (0.4%) | 19,904 (100.0%) |